FDA OKs first new ADHD drug in over a decade for children
The Food and Drug Administration late Friday OK’d Qelbree (KELL’-bree) for treating attention deficit hyperactivity disorder in children ages 6 to 17. It comes as a capsule that’s taken daily. Unlike nearly all other ADHD medicines, Qelbree is not a stimulant or a controlled substance, making it harder to abuse than older drugs.
Other Articles in this Edition
FDA OKs first new ADHD drug in over a decade for children
An ADHD medication has been recalled after contamination by another drug was found
College Can Really Ramp Up Stress for People With ADHD
Why teens with ADHD need more ZZZs to get to more As
How Technology Can Help You Cope With ADHD
Undiagnosed ADHD in women poses extra barriers to remote learning
Attention Deficit Hyperactivity Disorder Associates With Poorer Lifetime Occupational Success